zepbound is glp 1 Oksana Aron, M.D., Medical Weight Loss, New York GLP-1 Explained: The Good, the

Clinical trials and meta-analyses consistently show that DPP-4 inhibitors produce a modest but clinically meaningful reduction in HbA1c , typically in the range of: 0.5% to 1.0% (approximately 5.5 to 11 mmol/mol) when used as monotherapy or add-on therapy Reductions at the higher end of this range are more likely when baseline HbA1c is significantly elevated For example, sitagliptin has demonstrated reductions of around 0.60.8% in randomised controlled trials, while vildagliptin and saxagliptin show broadly comparable efficacy

Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV

Approximately 10-minutes post-exercise, another 15 mL of blood was taken from each subject

Can I take this supplement alongside other vitamins